Dow Up 0.05% Nasdaq Down 0.18%

Cerus Corporation (CERS)

-NasdaqGM
5.63 Down 0.20(3.43%) May 5, 4:00PM EDT
Prev Close:5.83
Open:5.82
Bid:5.55 x 200
Ask:6.09 x 400
1y Target Est:9.20
Beta:1.59462
Next Earnings Date:N/A
Day's Range:5.55 - 5.89
52wk Range:4.27 - 6.89
Volume:1,113,414
Avg Vol (3m):1,495,190
Market Cap:559.40M
P/E (ttm):N/A
EPS (ttm):-0.67
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CERS

Comparison

Symbol% ChgMkt Cap
CERSDown 3.43%559.40M
HAEUp 0.79%1.42B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.58
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.65
Quarterly EPS Est (Jun-16) :-0.17
Mean Recommendation*:1.2
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System is based on its proprietary technology for controlling biological replicatio... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback